apl. Prof. Dr. Stefan Krause



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Blood counts in adults and elderly individuals (2019) Zierk J, Krebs A, Rauh M, Metzler M, Parsch H, Strasser E, Krause S Conference contribution Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia (2018) Middeke JM, Rollig C, Kramer M, Kramer A, Bochtler T, Scholl S, Hochhaus A, et al. Conference contribution EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia (2018) Stasik S, Middeke JM, Kraemer M, Rollig C, Kramer A, Scholl S, Hochhaus A, et al. Conference contribution Nilotinib Vs Nilotinib Plus Pegylated Interferon-alpha2b Induction and Nilotinib or Pegylated Interferon-alpha2b Maintenance Therapy for Newly Diagnosed BCR-ABL plus Chronic Myeloid Leukemia Patients in Chronic Phase: Interim Analysis of the Tiger (CML V)-Study (2018) Hochhaus A, Saussele S, Baerlocher GM, Bruemmendorf TH, Burchert A, La Rosee P, Hasford J, et al. Conference contribution Label-Free High-Throughput Leukemia Detection by Holographic Microscopy (2018) Ugele M, Weniger M, Stanzel M, Bassler M, Krause S, Friedrich O, Hayden O, Richter L Journal article Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV (2018) Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, et al. Journal article Indirect determination of hematology reference intervals in adult patients on Beckman Coulter UniCell DxH 800 and Abbott CELL-DYN Sapphire devices (2018) Zierk J, Arzideh F, Haeckel R, Rauh M, Metzler M, Ganslandt T, Krause S Journal article Genital ulcers as diagnostic clue for acute myeloid leukaemia (2018) Schröder S, Krause S, Erfurt-Berge C Journal article Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells (2018) Braciak TA, Roskopf CC, Wildenhain S, Fenn NC, Schiller CB, Schubert IA, Jacob U, et al. Journal article Choosing wisely recommendations in hematology and oncology (2017) Krause S, Neubauer A Journal article